Literature DB >> 23695974

Selection and outcomes of living donors with a remnant volume less than 30% after right hepatectomy.

Seong Hoon Kim1, Young Kyu Kim, Seung Duk Lee, Sang-Jae Park.   

Abstract

The evidence for defining a safe minimal remnant volume after living donor hepatectomy is insufficient. The aim of this study was to evaluate the outcomes of living donors with a remnant/total volume ratio (RTVR) < 30% after right hepatectomy according to the following selection criteria: the preservation of the middle hepatic vein (MHV), an age < 50 years, and no or mild fatty changes in healthy adults. All living donors who underwent right hepatectomy preserving the MHV at our institution between January 2005 and September 2011 were divided into 2 groups: group A with an RTVR < 30% and group B with an RTVR ≥ 30%. Perioperative data, complications by the Clavien classification, and outcomes with at least 15.1 months' follow-up were compared. Twenty-eight donors were enrolled in group A, and 260 were enrolled in group B. The estimated liver volume was strongly correlated with the actual graft weight (R(2)  = 0.608, P < 0.001). The calculated donation liver volume and the RTVR were significantly different between the 2 groups (P = 0.03 and P < 0.001, respectively). The peak postoperative aspartate aminotransferase levels, alanine aminotransferase levels, and international normalized ratios did not differ between the 2 groups. The peak total bilirubin level was higher for group A versus group B (P = 0.04). The hospital stay was longer for group A versus group B (P < 0.001). All donors recovered completely, and there were no significant differences in overall complications between the 2 groups. In conclusion, right hepatectomy preserving the MHV with an RTVR < 30% can be safely indicated for carefully selected living donors less than 50 years old with no or mild fatty changes.
© 2013 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23695974     DOI: 10.1002/lt.23677

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  9 in total

1.  Proposal of new expanded selection criteria using total tumor size and (18)F-fluorodeoxyglucose - positron emission tomography/computed tomography for living donor liver transplantation in patients with hepatocellular carcinoma: The National Cancer Center Korea criteria.

Authors:  Seung Duk Lee; Bora Lee; Seong Hoon Kim; Jungnam Joo; Seok-Ki Kim; Young-Kyu Kim; Sang-Jae Park
Journal:  World J Transplant       Date:  2016-06-24

Review 2.  Pushing the frontiers of living donor right hepatectomy.

Authors:  Seong Hoon Kim; Seung Duk Lee; Young Kyu Kim; Sang-Jae Park
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

3.  Impact of ABO-incompatibility on hepatic artery thrombosis in living donor liver transplantation.

Authors:  Seong Hoon Kim; Jangho Park; Sang Jae Park
Journal:  Ann Transl Med       Date:  2019-11

4.  The Impact of a Surgical Protocol for Enhanced Recovery on Living Donor Right Hepatectomy: A Single-Center Cohort Study.

Authors:  Seong Hoon Kim; Young Kyu Kim; Seung Duk Lee; Eung Chang Lee; Sang Jae Park
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

5.  Safety and Efficacy of Once-Daily Prolonged-Release Tacrolimus in Living Donor Liver Transplantation: An Open-Label, Prospective, Single-Arm, Phase 4 Study.

Authors:  Eung Chang Lee; Seong Hoon Kim; Sang-Jae Park
Journal:  Ann Transplant       Date:  2018-10-12       Impact factor: 1.530

6.  Minimal Surgical Manpower for Living Donor Liver Transplantation.

Authors:  Seoung Hoon Kim; Jang Ho Park; Byoung Ho An
Journal:  J Clin Med       Date:  2022-07-24       Impact factor: 4.964

7.  Bilateral proficiency over time leads to reduced donor morbidity in living donor hepatectomy.

Authors:  Viola Huang; Chao-Long Chen; Yu-Hung Lin; Tsan-Shiun Lin; Chih-Che Lin; Shih-Ho Wang; Chee-Chien Yong; Chih-Yi Chen; Yu-Fan Cheng
Journal:  Hepatobiliary Surg Nutr       Date:  2019-10       Impact factor: 7.293

8.  Survival Analysis after Living Donor Liver Transplantation for Hepatocellular Carcinoma: A Single Center Cohort Study.

Authors:  Byung-Gon Na; Seong-Hoon Kim; Sang-Jae Park
Journal:  Biology (Basel)       Date:  2021-05-20

9.  Clinical Outcome of Residual Liver Volume and Hepatic Steatosis After Right-Lobe Living-Donor Hepatectomy.

Authors:  Chia-En Hsieh; Kuo-Hua Lin; Ya-Lan Hsu; Chen-Te Chou; Chia-Bang Chen; Ping-Yi Lin; Chia-Cheng Lin; Yu-Ju Hung; Li-Chueh Weng; Yao-Li Chen
Journal:  Ann Transplant       Date:  2020-03-10       Impact factor: 1.530

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.